Tzu‐yin Lin

3.1k citations

80 papers · 2.4k indexed · h-index 26

Biomedical Engineering top 2%
Molecular Biology top 10%
Biomaterials top 2%
Materials Chemistry top 10%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Yuanpei Li Kit S. Lam Hongyong Zhang Chong-xian Pan Xiangdong Xue Cheryl A. London Zhongling Wang Wenwu Xiao
Topics: Nanoplatforms for cancer theranostics (34 papers)Nanoparticle-Based Drug Delivery (21 papers)RNA Interference and Gene Delivery (9 papers)
Cited by: Biomaterials Biomedical Engineering Materials Chemistry
Journals: Advanced Materials Nature Communications Blood
Partner nations: United States China Taiwan

In The Last Decade

Tzu‐yin Lin

78 papers receiving 2.4k citations

Peers

Countries citing papers authored by Tzu‐yin Lin

Since Specialization

Citations

This map shows the geographic impact of Tzu‐yin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzu‐yin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzu‐yin Lin more than expected).

Fields of papers citing papers by Tzu‐yin Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tzu‐yin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzu‐yin Lin. The network helps show where Tzu‐yin Lin may publish in the future.

Co-authorship network of co-authors of Tzu‐yin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Tzu‐yin Lin. A scholar is included among the top collaborators of Tzu‐yin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tzu‐yin Lin. Tzu‐yin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy 2025 ·Small Science ·(unknown),Raffaella Villa,(unknown),Menghuan Tang,(unknown),(unknown),(unknown),(unknown),(unknown),Andrew C. Birkeland,Tzu‐yin Lin,Yuanpei Li	6
2	Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment 2023 ·Journal of Controlled Release ·Haijing Qu,Jinfan Yang,(unknown),(unknown),Xin Zhou,Xiangdong Xue,Dalin Zhang,(unknown),(unknown),Mythili Ramachandran,(unknown),Yi Wu,(unknown),Hao Wu,Xiaobin Ma,Tzu‐yin Lin,Yuanpei Li	11
3	A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers 2023 ·Biomaterials ·Xiangdong Xue,Haijing Qu,Ruonan Bo,Dalin Zhang,Zheng Zhu,Bai Xiang,(unknown),(unknown),Chong-xian Pan,Tzu‐yin Lin,Yuanpei Li	19
4	Drug-drug conjugates self-assembled nanomedicines triggered photo−/immuno- therapy for synergistic cancer treatments 2023 ·Journal of Controlled Release ·Haijing Qu,(unknown),Han Chen,Menghuan Tang,Wei Cheng,Tzu‐yin Lin,Lingyan Li,Bin Li,Xiangdong Xue	25
5	Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer 2022 ·Clinical Cancer Research ·Zheng Zhu,Ai‐Hong Ma,Hongyong Zhang,Tzu‐yin Lin,Xiangdong Xue,Hizra Farrukh,Shaoming Zhu,Wei Shi,Yuan Ruan,(unknown),Veera Chandra Sekhar Reddy Chittepu,(unknown),Yuanpei Li,Kit S. Lam,Chong-xian Pan	19
6	Author Correction: Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy 2021 ·Nature Communications ·Zhao Ma,Jin Li,Kai Lin,Mythili Ramachandran,Dalin Zhang,Megan R. Showalter,Cristabelle De Souza,Aaron Lindstrom,(unknown),Bei Jia,Shiro Urayama,Yuyou Duan,Oliver Fiehn,Tzu‐yin Lin,Minyong Li,Yuanpei Li	3
7	Novel Nanococktail of a Dual PI3K/mTOR Inhibitor and Cabazitaxel for Castration‐Resistant Prostate Cancer 2020 ·Advanced Therapeutics ·Yee Huang,Xiangdong Xue,Xiaocen Li,Bei Jia,Chong-xian Pan,Yuanpei Li,Tzu‐yin Lin	11
8	Sequential Targeting in Crosslinking Nanotheranostics for Tackling the Multibarriers of Brain Tumors 2020 ·Advanced Materials ·Hao Wu,Hongwei Lu,Wenwu Xiao,Jinfan Yang,(unknown),(unknown),Haijing Qu,Bei Jia,(unknown),Mythili Ramachandran,Xiangdong Xue,Zhao Ma,Xiaobao Xu,Zhongling Wang,Yixuan He,Kit S. Lam,Robert J. Zawadzki,Yuanpei Li,Tzu‐yin Lin	64
9	Single Small Molecule‐Assembled Mitochondria Targeting Nanofibers for Enhanced Photodynamic Cancer Therapy In Vivo 2020 ·Advanced Functional Materials ·Kai Lin,Zhao Ma,Jin Li,Menghuan Tang,Aaron Lindstrom,Mythili Ramachandran,Shaoming Zhu,Tzu‐yin Lin,Lanwei Zhang,Yuanpei Li	58
10	Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging 2020 ·Nature Nanotechnology ·Zhongling Wang,Xiangdong Xue,Hongwei Lu,Yixuan He,Ziwei Lu,Zhijie Chen,Ye Yuan,Na Tang,Courtney A. Dreyer,(unknown),N. J. Curro,Kit S. Lam,Jeffrey H. Walton,Tzu‐yin Lin,Angelique Y. Louie,Dustin A. Gilbert,Kai Liu,Katherine W. Ferrara,Yuanpei Li	120
11	Self‐Assembled Nanoparticle‐Mediated Chemophototherapy Reverses the Drug Resistance of Bladder Cancers through Dual AKT/ERK Inhibition 2020 ·Advanced Therapeutics ·Weimin Yu,Xiangdong Xue,Ai‐Hong Ma,Yuan Ruan,Hongyong Zhang,Cheng Fan,Yuanpei Li,Chong-xian Pan,Tzu‐yin Lin	14
12	Hyaluronic acid is required for palatal shelf movement and its interaction with the tongue during palatal shelf elevation 2019 ·Developmental Biology ·(unknown),Tzu‐yin Lin,Kai Yu	12
13	A polymer-free, biomimicry drug self-delivery system fabricatedviaa synergistic combination of bottom-up and top-down approaches 2018 ·Journal of Materials Chemistry B ·Xiaobao Xu,Gaomai Yang,Xiangdong Xue,Hongwei Lu,Hao Wu,Yee Huang,Di Jing,Wenwu Xiao,Jingkui Tian,Wei Yao,Chong‐Xian Pan,Tzu‐yin Lin,Yuanpei Li	14
14	Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment 2018 ·Nature Communications ·Xiangdong Xue,Yee Huang,Ruonan Bo,Bei Jia,Hao Wu,Ye Yuan,Zhongling Wang,Zhao Ma,Di Jing,Xiaobao Xu,Weimin Yu,Tzu‐yin Lin,Yuanpei Li	171
15	A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging 2018 ·Nanoscale ·Ye Yuan,Yixuan He,Ruonan Bo,Zhao Ma,Zhongling Wang,Lijie Dong,Tzu‐yin Lin,Xiangdong Xue,Yuanpei Li	21
16	The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer 2017 ·Clinical Cancer Research ·Shuxiong Zeng,Yanjun Zhu,Ai-Hong Ma,Weimin Yu,Hongyong Zhang,Tzu‐yin Lin,Wei Shi,Clifford G. Tepper,Paul T. Henderson,Susan Airhart,(unknown),(unknown),Ralph W. deVere White,Chong-xian Pan	44
17	A facile strategy for fine-tuning the stability and drug release of stimuli-responsive cross-linked micellar nanoparticles towards precision drug delivery 2017 ·Nanoscale ·Kai Xiao,Tzu‐yin Lin,Kit S. Lam,Yuanpei Li	22
18	Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer 2017 ·Journal of Controlled Release ·Wenwu Xiao,(unknown),Kai Xiao,Tzu‐yin Lin,(unknown),Kit S. Lam,Yuanpei Li	19
19	Sub-100 nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy 2017 ·Journal of Controlled Release ·(unknown),Xiangdong Xue,Yan Luo,Tzu‐yin Lin,Hongyong Zhang,Diana Lac,Kai Xiao,Yixuan He,Bei Jia,Kit S. Lam,Yuanpei Li	39
20	Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer 2016 ·PLoS ONE ·(unknown),Hongyong Zhang,(unknown),Maike Zimmermann,Bin Hu,(unknown),Ruth L. Vinall,Tzu‐yin Lin,George D. Cimino,Patrick Chain,Momchilo Vuyisich,Cheryl D. Gleasner,Kim McMurry,Michael Malfatti,Kenneth W. Turteltaub,(unknown),Chong-xian Pan,(unknown)	13

About Tzu‐yin Lin

Tzu‐yin Lin is a scholar working on Biomaterials, Biomedical Engineering and Biotechnology, having authored 80 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (34 papers), Nanoparticle-Based Drug Delivery (21 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Biomaterials (682 citations), Biomedical Engineering (1.3k citations) and Materials Chemistry (643 citations). Tzu‐yin Lin has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Yuanpei Li, Kit S. Lam, Hongyong Zhang, Chong-xian Pan, Xiangdong Xue, Cheryl A. London, Zhongling Wang, Wenwu Xiao, Diana Lac and Ye Yuan. Their work appears in journals such as Advanced Materials, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact